THC Therapeutics, Inc. - 10-Q filing on 2013-03-21

SUBSEQUENT EVENTS	6 Months Ended
Jan. 31, 2013
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to January 31, 2013 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.

SUBSEQUENT EVENTS

6 Months Ended

Jan. 31, 2013

In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to January 31, 2013 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.